MDPHP (3',4'-Methylenedioxy-α-pyrrolidinohexiophenone) is a
stimulant of the
cathinone class originally developed in the 1960s,[1] which has been reported as a novel
designer drug. In the UK its slang name is monkey dust.[2][3] It is closely related to the potent stimulant
MDPV though with slightly milder effects, and has been used as an alternative in some countries following the banning of MDPV.[4][5][6][7]
MDPHP is specifically listed as a controlled substance in Japan [9] and Hungary,[10] and is controlled under
analogue provisions in a number of other jurisdictions.
Documented fatalities
A case of a "fatal acute intoxication caused by MDPHP" in a 48 year old male was reported in February 2022 by physicians at an Italian hospital.[11]
^DE 1545591, Koeppe H, Zeile K, Ludwig G, "Patent DE - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe", issued 28 May 1965
^Zaitsu K, Katagi M, Tsuchihashi H, Ishii A (2013). "Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: A review of their pharmacology, acute toxicity, and metabolism". Forensic Toxicology. 32: 1–8.
doi:
10.1007/s11419-013-0218-1.
S2CID25604845.
^Kaizaki-Mitsumoto A, Noguchi N, Yamaguchi S, Odanaka Y, Matsubayashi S, Kumamoto H, et al. (January 2016). "Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market". Forensic Toxicology. 34 (1): 108–14.
doi:
10.1007/s11419-015-0293-6.
S2CID45890497.
^"指定薬物名称・構造式一覧(平成27年9月16日現在)" [List of designated drug names and structural formulas (as of September 16, 2015)] (PDF) (in Japanese). 厚生労働省 (Ministry of Health, Labour and Welfare). 16 September 2015. Retrieved 8 October 2015.
MDPHP (3',4'-Methylenedioxy-α-pyrrolidinohexiophenone) is a
stimulant of the
cathinone class originally developed in the 1960s,[1] which has been reported as a novel
designer drug. In the UK its slang name is monkey dust.[2][3] It is closely related to the potent stimulant
MDPV though with slightly milder effects, and has been used as an alternative in some countries following the banning of MDPV.[4][5][6][7]
MDPHP is specifically listed as a controlled substance in Japan [9] and Hungary,[10] and is controlled under
analogue provisions in a number of other jurisdictions.
Documented fatalities
A case of a "fatal acute intoxication caused by MDPHP" in a 48 year old male was reported in February 2022 by physicians at an Italian hospital.[11]
^DE 1545591, Koeppe H, Zeile K, Ludwig G, "Patent DE - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe", issued 28 May 1965
^Zaitsu K, Katagi M, Tsuchihashi H, Ishii A (2013). "Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: A review of their pharmacology, acute toxicity, and metabolism". Forensic Toxicology. 32: 1–8.
doi:
10.1007/s11419-013-0218-1.
S2CID25604845.
^Kaizaki-Mitsumoto A, Noguchi N, Yamaguchi S, Odanaka Y, Matsubayashi S, Kumamoto H, et al. (January 2016). "Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market". Forensic Toxicology. 34 (1): 108–14.
doi:
10.1007/s11419-015-0293-6.
S2CID45890497.
^"指定薬物名称・構造式一覧(平成27年9月16日現在)" [List of designated drug names and structural formulas (as of September 16, 2015)] (PDF) (in Japanese). 厚生労働省 (Ministry of Health, Labour and Welfare). 16 September 2015. Retrieved 8 October 2015.